Search
Ultragenyx Pharmaceutical Inc
RAREAdd to Watchlist
14.960USD
+0.460+3.17%
Market hours 09/18, 15:06（ET）
1.48BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+3.17%
5 Days
+3.89%
1 Month
-42.75%
6 Months
-30.74%
Year to Date
-34.96%
1 Year
-47.89%
Key Figures
14.740Open
15.070High
577.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.59%Turnover Ratio
14.500Prev. Close
14.100Low
8.46MTurnover
LossP/E Static
-5.07P/B
0.00%Div Yield TTM
-46.70%ROA
39.89052wk High
0.10Volume Ratio
-569.18MNet Profit
98.60MShares
-6.1016EPS TTM
0.37Beta
-656.03%ROE
12.73052wk Low
6.69%Amplitude
84.11%Gross Margin
1.48BMarket Cap
-2.31Reward/Risk
5.15%Risk Rate
Ultragenyx Pharmaceutical Inc's Score
0.12vs previous score
Forecast7.50
Financial Health7.58
Technical6.82
Valuation Dimensions8.65
Institutional Confidence10.00
Risk Assessment3.18
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Ultragenyx Pharmaceutical Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.90/-1.23
Revenue / Forecast
214.00M/180.24M
Ultragenyx Pharmaceutical Inc Profile
SectorPharmaceuticals
Ticker SymbolRARE
Number of employees1294
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Portfolio Management, LLC | 5.47% |
| BlackRock Institutional Trust Company, N.A. | 5.47% |
| State Street Investment Management (US) | 5.10% |
| Vanguard Capital Management, LLC | 4.25% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 47.10% |
| Investment Advisor/Hedge Fund | 25.80% |
| Hedge Fund | 17.03% |
| Research Firm | 4.75% |
Related Instruments
+0.28%
+0.51%
+0.34%
+0.38%
-0.29%
-0.44%
+1.72%
+0.35%
-0.20%
+0.69%
-1.11%
-0.21%
-1.57%
-1.44%
-0.17%
+0.01%
-0.25%
-2.19%
-0.29%
-0.48%Popular Instruments
51710.400
-49.600 (-0.10%)
29545.400
+132.700 (+0.45%)
7643.000
+10.900 (+0.14%)
14401.000
+100.000 (+0.70%)
65008.000
+59.000 (+0.09%)
6227.000
-80.200 (-1.27%)
96.131
-1.855 (-1.89%)
335.900
-1.100 (-0.33%)
219.460
+0.120 (+0.06%)
4381.670
+40.690 (+0.94%)
FAQs
What is the current price of Ultragenyx Pharmaceutical Inc (RARE)?
The current price of Ultragenyx Pharmaceutical Inc (RARE) is 14.50.
What is the symbol of Ultragenyx Pharmaceutical Inc?
The ticker symbol of Ultragenyx Pharmaceutical Inc is RARE.
What is the 52-week high of Ultragenyx Pharmaceutical Inc?
The 52-week high of Ultragenyx Pharmaceutical Inc is 39.89.
What is the 52-week low of Ultragenyx Pharmaceutical Inc?
The 52-week low of Ultragenyx Pharmaceutical Inc is 12.73.
What is the market capitalization of Ultragenyx Pharmaceutical Inc?
The market capitalization of Ultragenyx Pharmaceutical Inc is 1.43B.
Is Ultragenyx Pharmaceutical Inc (RARE) currently rated as Buy, Hold, or Sell?
According to analysts, Ultragenyx Pharmaceutical Inc (RARE) has an overall rating of Buy, with a price target of 25.17.
What is the Earnings Per Share (EPS TTM) of Ultragenyx Pharmaceutical Inc (RARE)?
The Earnings Per Share (EPS TTM) of Ultragenyx Pharmaceutical Inc (RARE) is -6.10.